Your browser doesn't support javascript.
loading
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.
Pather, Shanti; Madhi, Shabir A; Cowling, Benjamin J; Moss, Paul; Kamil, Jeremy P; Ciesek, Sandra; Muik, Alexander; Türeci, Özlem.
Affiliation
  • Pather S; BioNTech, Mainz, Germany.
  • Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Cowling BJ; School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Kamil JP; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, United States.
  • Ciesek S; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.
  • Muik A; BioNTech, Mainz, Germany.
  • Türeci Ö; BioNTech, Mainz, Germany.
Front Immunol ; 14: 1232965, 2023.
Article in En | MEDLINE | ID: mdl-37377964
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2023.1130539.].
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Immunol Year: 2023 Type: Article Affiliation country: Germany